Literature DB >> 23154222

Recognition of CD1d-restricted antigens by natural killer T cells.

Jamie Rossjohn1, Daniel G Pellicci, Onisha Patel, Laurent Gapin, Dale I Godfrey.   

Abstract

Natural killer T (NKT) cells are innate-like T cells that rapidly produce a variety of cytokines following T cell receptor (TCR) activation and can shape the immune response in many different settings. There are two main NKT cell subsets: type I NKT cells are typically characterized by the expression of a semi-invariant TCR, whereas the TCRs expressed by type II NKT cells are more diverse. This Review focuses on the defining features and emerging generalities regarding how NKT cells specifically recognize self, microbial and synthetic lipid-based antigens that are presented by CD1d. Such information is vitally important to better understand, and fully harness, the therapeutic potential of NKT cells.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23154222      PMCID： PMC3740582          DOI： 10.1038/nri3328

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


  131 in total

1.  Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d.

Authors:  Ya-Hui Chiu; Se-Ho Park; Kamel Benlagha; Claire Forestier; Jayanthi Jayawardena-Wolf; Paul B Savage; Luc Teyton; Albert Bendelac
Journal:  Nat Immunol       Date:  2001-12-03       Impact factor: 25.606

Review 2.  NKT cells: what's in a name?

Authors:  Dale I Godfrey; H Robson MacDonald; Mitchell Kronenberg; Mark J Smyth; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

3.  T cell allorecognition via molecular mimicry.

Authors:  Whitney A Macdonald; Zhenjun Chen; Stephanie Gras; Julia K Archbold; Fleur E Tynan; Craig S Clements; Mandvi Bharadwaj; Lars Kjer-Nielsen; Philippa M Saunders; Matthew C J Wilce; Fran Crawford; Brian Stadinsky; David Jackson; Andrew G Brooks; Anthony W Purcell; John W Kappler; Scott R Burrows; Jamie Rossjohn; James McCluskey
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

4.  Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor.

Authors:  Onisha Patel; Daniel G Pellicci; Stephanie Gras; Maria L Sandoval-Romero; Adam P Uldrich; Thierry Mallevaey; Andrew J Clarke; Jérôme Le Nours; Alex Theodossis; Susanna L Cardell; Laurent Gapin; Dale I Godfrey; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2012-07-22       Impact factor: 25.606

5.  Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.

Authors:  Daniel G Pellicci; Onisha Patel; Lars Kjer-Nielsen; Siew Siew Pang; Lucy C Sullivan; Konstantinos Kyparissoudis; Andrew G Brooks; Hugh H Reid; Stephanie Gras; Isabelle S Lucet; Ruide Koh; Mark J Smyth; Thierry Mallevaey; Jennifer L Matsuda; Laurent Gapin; James McCluskey; Dale I Godfrey; Jamie Rossjohn
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

6.  Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.

Authors:  Karsten Fischer; Emmanuel Scotet; Marcus Niemeyer; Heidrun Koebernick; Jens Zerrahn; Sophie Maillet; Robert Hurwitz; Mischo Kursar; Marc Bonneville; Stefan H E Kaufmann; Ulrich E Schaible
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-08       Impact factor: 11.205

7.  Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation.

Authors:  Jin S Im; Pooja Arora; Gabriel Bricard; Alberto Molano; Manjunatha M Venkataswamy; Ian Baine; Elliot S Jerud; Michael F Goldberg; Andres Baena; Karl O A Yu; Rachel M Ndonye; Amy R Howell; Weiming Yuan; Peter Cresswell; Young-Tae Chang; Petr A Illarionov; Gurdyal S Besra; Steven A Porcelli
Journal:  Immunity       Date:  2009-06-19       Impact factor: 31.745

8.  The molecular basis for recognition of CD1d/α-galactosylceramide by a human non-Vα24 T cell receptor.

Authors:  Jacinto López-Sagaseta; Jennifer E Kung; Paul B Savage; Jenny Gumperz; Erin J Adams
Journal:  PLoS Biol       Date:  2012-10-23       Impact factor: 8.029

9.  Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain.

Authors:  S Porcelli; C E Yockey; M B Brenner; S P Balk
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

10.  Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation.

Authors:  Dale Christiansen; Julie Milland; Effie Mouhtouris; Hilary Vaughan; Daniel G Pellicci; Malcolm J McConville; Dale I Godfrey; Mauro S Sandrin
Journal:  PLoS Biol       Date:  2008-07-15       Impact factor: 8.029
View more
  204 in total

1.  Glycolipid iGb3 feedback amplifies innate immune responses via CD1d reverse signaling.

Authors:  Xingguang Liu; Peng Zhang; Yunkai Zhang; Zheng Wang; Sheng Xu; Yingke Li; Wanwan Huai; Qingqing Zhou; Xiang Chen; Xi Chen; Nan Li; Peng Wang; Yunsen Li; Xuetao Cao
Journal:  Cell Res       Date:  2018-12-04       Impact factor: 25.617

Review 2.  Lipid antigens in immunity.

Authors:  C Marie Dowds; Sabin-Christin Kornell; Richard S Blumberg; Sebastian Zeissig
Journal:  Biol Chem       Date:  2014-01       Impact factor: 3.915

3.  Self-glycerophospholipids activate murine phospholipid-reactive T cells and inhibit iNKT cell activation by competing with ligands for CD1d loading.

Authors:  Ramesh Chandra Halder; Cynthia Tran; Priti Prasad; Jing Wang; Dhiraj Nallapothula; Tatsuya Ishikawa; Meiying Wang; Dirk M Zajonc; Ram Raj Singh
Journal:  Eur J Immunol       Date:  2018-12-18       Impact factor: 5.532

Review 4.  Lipids hide or step aside for CD1-autoreactive T cell receptors.

Authors:  Rachel N Cotton; Adam Shahine; Jamie Rossjohn; D Branch Moody
Journal:  Curr Opin Immunol       Date:  2018-05-05       Impact factor: 7.486

Review 5.  Human cell-based artificial antigen-presenting cells for cancer immunotherapy.

Authors:  Marcus O Butler; Naoto Hirano
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 6.  Natural Killer T cell obsession with self-antigens.

Authors:  Laurent Gapin; Dale I Godfrey; Jamie Rossjohn
Journal:  Curr Opin Immunol       Date:  2013-02-04       Impact factor: 7.486

Review 7.  Lipid and small-molecule display by CD1 and MR1.

Authors:  Ildiko Van Rhijn; Dale I Godfrey; Jamie Rossjohn; D Branch Moody
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

Review 8.  Commensal microbiota and NKT cells in the control of inflammatory diseases at mucosal surfaces.

Authors:  Sebastian Zeissig; Richard S Blumberg
Journal:  Curr Opin Immunol       Date:  2013-11-05       Impact factor: 7.486

9.  Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response.

Authors:  Jie Zhao; Xiufang Weng; Sreya Bagchi; Chyung-Ru Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

10.  Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells.

Authors:  Dingding An; Sungwhan F Oh; Torsten Olszak; Joana F Neves; Fikri Y Avci; Deniz Erturk-Hasdemir; Xi Lu; Sebastian Zeissig; Richard S Blumberg; Dennis L Kasper
Journal:  Cell       Date:  2014-01-16       Impact factor: 41.582
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.